The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-(2-oxo-1-(2-(1-(3-(trifluoromethyl)phenyl)ethyl)-1H-imidazol-4-yl)-1,2-dihydropyridin-4-yl)thiazole-4-carboxamide ID: ALA3810245
PubChem CID: 74223859
Max Phase: Preclinical
Molecular Formula: C21H16F3N5O2S
Molecular Weight: 459.45
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CC(c1cccc(C(F)(F)F)c1)c1nc(-n2ccc(NC(=O)c3cscn3)cc2=O)c[nH]1
Standard InChI: InChI=1S/C21H16F3N5O2S/c1-12(13-3-2-4-14(7-13)21(22,23)24)19-25-9-17(28-19)29-6-5-15(8-18(29)30)27-20(31)16-10-32-11-26-16/h2-12H,1H3,(H,25,28)(H,27,31)
Standard InChI Key: KNZCGSFVJLIXLJ-UHFFFAOYSA-N
Molfile:
RDKit 2D
32 35 0 0 0 0 0 0 0 0999 V2000
1.2990 -0.7500 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.6003 1.4977 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.8990 0.7455 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.2003 1.4932 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8969 -0.4545 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.3383 1.3500 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-6.5517 0.8722 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-7.5554 1.9869 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
-6.8054 3.2859 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.3382 2.9741 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.5987 -1.5004 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9511 -0.8815 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9531 -1.9978 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.2010 -3.2956 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7343 -2.9815 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.8054 -4.6666 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9195 -5.8781 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5226 -7.2516 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6348 -8.4606 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1439 -8.2963 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5407 -6.9229 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4285 -5.7138 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2383 -9.8348 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4310 -9.9670 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
3.5278 -10.8018 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
4.7203 -10.9337 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
5.9984 -4.7960 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
1 6 1 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
4 7 1 0
7 8 1 0
8 9 1 0
8 10 2 0
2 11 2 0
9 12 2 0
12 13 1 0
13 14 1 0
14 15 2 0
15 9 1 0
1 16 1 0
16 17 2 0
17 18 1 0
18 19 1 0
19 20 2 0
20 16 1 0
19 21 1 0
21 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 26 1 0
26 27 2 0
27 22 1 0
24 28 1 0
28 29 1 0
28 30 1 0
28 31 1 0
21 32 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 459.45Molecular Weight (Monoisotopic): 459.0977AlogP: 4.44#Rotatable Bonds: 5Polar Surface Area: 92.67Molecular Species: NEUTRALHBA: 6HBD: 2#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 11.75CX Basic pKa: 1.27CX LogP: 3.43CX LogD: 3.43Aromatic Rings: 4Heavy Atoms: 32QED Weighted: 0.46Np Likeness Score: -1.73
References 1. Fader L, Brault M, Desjardins J, Dansereau N, Lamorte L, Tremblay S, Bilodeau F, Bordeleau J, Duplessis M, Gorys V, Gillard J, Gleason JL, James C, Joly MA, Kuhn C, Llinas-Brunet M, Luo L, Morency L, Morin S, Parisien M, Poirier M, Thibeault C, Trinh T, Sturino C, Srivastava S, Yoakim C, Franti M.. (2016) Discovery of Potent, Orally Bioavailable Inhibitors of Human Cytomegalovirus., 7 (5): [PMID:27190604 ] [10.1021/acsmedchemlett.6b00064 ]